Maunsell Farris Maryanne
Reporting owner on Forms 3, 4 and 5, CIK 1950052.
Maunsell Farris Maryanne reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| HAE · HAEMONETICS CORPCIK 313143 | officer (VP, Chief Accounting Officer) | 1 | 2026-11-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| HAE · HAEMONETICS CORPCommon Stock | 2026-11-11 | M exercised | +1,068 | $89.16 | 7,310 | Form 4 |
| HAE · HAEMONETICS CORPCommon Stock | 2026-11-11 | M exercised | +645 | $95.73 | 7,955 | Form 4 |
| HAE · HAEMONETICS CORPCommon Stock | 2026-11-11 | M exercised | +433 | $70.31 | 8,388 | Form 4 |
| HAE · HAEMONETICS CORPCommon Stock | 2026-11-11 | F withheld for tax | -1,724 | $121.1 | 6,664 | Form 4 |
| HAE · HAEMONETICS CORPCommon Stock | 2026-11-11 | S sold | -836 | $120.99 | 5,828 | Form 4 |
| HAE · HAEMONETICS CORPNon-qualified Stock Option (Right to Bu…, derivative | 2026-11-11 | M exercised | -1,068 | $0 | 357 | Form 4 |
| HAE · HAEMONETICS CORPNon-qualified Stock Option (Right to Bu…, derivative | 2026-11-11 | M exercised | -645 | $0 | 646 | Form 4 |
| HAE · HAEMONETICS CORPNon-qualified Stock Option (Right to Bu…, derivative | 2026-11-11 | M exercised | -433 | $0 | 1,299 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000313143-26-000155 | HAEMONETICS CORP | 2026-11-13 |